Literature DB >> 5703023

Immunopharmacologic activity of 1-aminocyclopentane-1-carboxylic acid.

M E Rosenthale, M I Gluckman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5703023     DOI: 10.1007/bf02146638

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


× No keyword cloud information.
  13 in total

1.  Mechanism of antitumour action of 1-amino-cyclopentane carboxylic acid.

Authors:  L BERLINGUET; N BEGIN; N K SARKAR
Journal:  Nature       Date:  1962-06-16       Impact factor: 49.962

2.  Biochemical studies of an unnatural and antitumor amino acid: 1-aminocyclopentanecarboxylic acid. II. Effects on cellular respiration and amino acid metabolism.

Authors:  L BERLINGUET; N BEGIN; L M BABINEAU; R O LAFERTE
Journal:  Can J Biochem Physiol       Date:  1962-04

3.  Excretion of 1-aminocyclopentanecarboxylic acid in man and the rat.

Authors:  H N CHRISTENSEN; J A CLIFFORD
Journal:  Biochim Biophys Acta       Date:  1962-07-30

4.  Transfer of amino acids across the intestine: a new model amino acid.

Authors:  H AKEDO; H N CHRISTENSEN
Journal:  J Biol Chem       Date:  1962-01       Impact factor: 5.157

5.  Impairment of tumor growth by unnatural amino acids.

Authors:  F MARTEL; L BERLINGUET
Journal:  Can J Biochem Physiol       Date:  1959-03

6.  Reversal of toxicity of 1-aminocyclopentanecarboxylic acid by valine in Escherichia coli.

Authors:  C J Abshire; R Pineau
Journal:  Can J Biochem       Date:  1967-10

7.  Induction of periarthritis by oral administration of 6-sulfanilamidoindazole and its treatment in rats.

Authors:  E B Sigg; M L Graeme; M John
Journal:  J Pharmacol Exp Ther       Date:  1967-07       Impact factor: 4.030

8.  Food intake, weight gain and amino acid pools of rats receiving 1-aminocyclopentaine-1-carboxylic acid.

Authors:  A J Clark; O Matsutani; M E Swendseid
Journal:  Proc Soc Exp Biol Med       Date:  1967-04

9.  Aminoaciduria resulting from cycloleucine administration in man.

Authors:  R R Brown
Journal:  Science       Date:  1967-07-28       Impact factor: 47.728

10.  PRELIMINARY PHASE II TRIALS WITH 1-AMINOCYCLOPENTANE CARBOXYLIC ACID (NSC-1026).

Authors:  R O JOHNSON
Journal:  Cancer Chemother Rep       Date:  1963-10
View more
  1 in total

Review 1.  Animal models of multiple sclerosis--potentials and limitations.

Authors:  Eilhard Mix; Hans Meyer-Rienecker; Hans-Peter Hartung; Uwe K Zettl
Journal:  Prog Neurobiol       Date:  2010-06-15       Impact factor: 11.685

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.